Navigation Links
How yeast is helping us to understand Parkinson's Disease
Date:2/27/2009

Teams of scientists from Australia and the United States have used yeast and mammalian cells to discover a connection between genetic and environmental causes of Parkinson's disease.

Yeasts are single cell organisms, used widely in biological research because their structure resembles that of cells found in animals and humans. Yeasts share many genes, or their functional equivalents, with humans and offer the ability to screen or test thousands of genes and analysing their effects.

Two genes (alpha-synuclein and PARK9) had separately been associated with forms of Parkinson's disease, while manganese poisoning can cause PD-like symptoms in miners and welders exposed to high manganese levels. Findings connecting alpha-synuclein, PARK9 and sensitivity to manganese, made possible by yeast research, have been published online in the February issue of the prestigious international journal, Nature Genetics.

"This is the first time that we've been able to connect three pieces of the Parkinson's disease jigsaw puzzle and it tells us we're on the right track to understanding what goes wrong in this disease" said Dr Antony Cooper from Sydney's Garvan Institute of Medical Research and head of the project group in Australia.

Parkinson's disease involves the degeneration of neurons that produce the neurotransmitter dopamine. Autopsies show an abundance of the small protein alpha-synuclein in affected regions of the brain, so scientists have known for some time that over-expression of the protein is toxic.

When a European group discovered PARK9's involvement in an inherited form of Parkinson's disease they examined some of the surviving neurons from patients who had 'sporadic' Parkinson's, as opposed to inherited forms of the disease, and found they contained ten times the levels of PARK9 when compared with similar parts of the brain in patients without the disease.

"Its possible that the surviving neurons remained functional, unlike the degenerated neurons surrounding them, because high levels of PARK9 protected them in some way," said Cooper.

"Little was known of PARK9's function but as yeast contains an equivalent gene, we were able to analyse its function."

"We found that high levels of the PARK9 in a cell diminish the toxic effects of alpha-synuclein. We also found that it appears to be a manganese pump, capable in theory of removing excess levels of the metal from cells."

"We need to know what is happening at the critical early stages of the disease, so that we can stop it, but we only get to examine human brains after death, when the damage has been done. Using yeast allows us to examine the early damaging stages."

A key, and perplexing, question for researchers in the field has been whether or not there is a single cause, or related group of genetic determinants, that result in dopaminergic neuron loss, or 'Parkinson's disease'.

"We would love to be able to link all the genes that we know have something to do with Parkinson's disease," said Cooper. "If you discover there's a central pathway involved, it provides much better potential for finding a successful treatment"

"So far, we've linked PARK9, alpha-synuclein and manganese toxicity. These linkages are not coincidental. They're likely to be affecting a pathway and we suspect it's a central pathway. To confirm that would be very exciting indeed."

Dr Cooper has been collaborating for several years with Dr Susan Lindquist, from the Whitehead Institute for Biomedical Research and Dr Aaron Gitler, from the University of Pennsylvania School of Medicine, to find how alpha-synuclein can damage cells.

To confirm that their results were not specific to yeast alone, Gitler, Cooper and Lindquist collaborated with Associate Professor Guy Caldwell, from the University of Alabama, and Associate Professor Jean-Christophe Rochet from the University of Purdue in Indiana, who verified their results in other Parkinson model systems.

"We wanted to check our findings were relevant in other Parkinson's models, because the more models it fits into, the more you believe it's real," said Cooper.


'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-043-407-1326
Research Australia
Source:Eurekalert

Related medicine news :

1. Yeast mimics severity of mutations leading to fatal childhood illness
2. Genetic Approach Boosts Yeast Infection Treatment
3. Fish oil and red yeast rice studied for lowering blood cholesterol
4. New research on mutation in yeast can enhance understanding of human diseases
5. Chinese Red Yeast Rice May Prevent Heart Attack
6. Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence
7. Yeast gives rise to new concept: cell fuel is brains behind division
8. Penn researchers find potential in yeast for selecting Lou Gehrigs disease drugs
9. Common misdiagnosis: most women believe they have a yeast infection when they dont
10. Aurora Leader Awarded for Helping Others Reach Their Potential
11. Helping to Clear the Air for Consumers - New Certification Standard for HEPA Filters Will Help Millions of People Make More Educated Choices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... The V Foundation for Cancer ... a Moment to Lose fundraising campaign. As the V Foundation’s boldest initiative to ... over cancer. The campaign aims to raise $200 million by 2020 and strategically ...
(Date:12/6/2016)... ... December 06, 2016 , ... Just in time for the holiday ... chocolate chip cookie recipe for Honeyville’s new Organic Quinoa Flour product for sale at ... in the near future. , “I think it’s wonderful that a growing number ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... recount of a powerful woman's story of sacrifice and enlightenment. , ... published author, Carolyn Fryer. Always looking for creative outlets, Carolyn gravitated toward writing ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... only authorized OSHA Training Institute Education Center headquartered in Northern California, has announced ... on providing occupational safety and health training to public sector employees. , “The ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Pa. , Dec. 5, 2016  Pennsylvania Physician ... Drug and Alcohol Programs Gary Tennis today ... drug, at Minnich,s Pharmacy in York ... order signed by Dr. Levine as a prescription to ... "It,s important to remember that any Pennsylvanian ...
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... Sanovas, Inc., a life science asset holding company ... wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed Intubation ... http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed annually ...
Breaking Medicine Technology: